Richard Aldrich, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 16,946 shares at $20.78 ($356K) on 2018-01-31, disclosed to the SEC on 2018-02-01.
Open-market sale of $356k CNCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.33 | 5,000 | $107K | 29.9% |
| 2 | $21.33 | 5,000 | $107K | 29.9% |
| 3 | $20.78 | 4,700 | $98K | 27.4% |
| 4 | $21.29 | 300 | $6K | 1.8% |
| 5 | $19.99 | 1,946 | $39K | 10.9% |
| Total | $21.02 avg | 16,946 |
| $356K |
| 100% |
| Filing → |
| CNCE | SELL | 2018-01-29 | $434K | — | Filing → |
| CNCE | SELL | 2018-01-24 | $689K | — | Filing → |
| CNCE | SELL | 2018-01-19 | $580K | — | Filing → |